Your browser doesn't support javascript.
loading
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.
Seibold, Petra; Webb, Adam; Aguado-Barrera, Miguel E; Azria, David; Bourgier, Celine; Brengues, Muriel; Briers, Erik; Bultijnck, Renée; Calvo-Crespo, Patricia; Carballo, Ana; Choudhury, Ananya; Cicchetti, Alessandro; Claßen, Johannes; Delmastro, Elena; Dunning, Alison M; Elliott, Rebecca M; Fachal, Laura; Farcy-Jacquet, Marie-Pierre; Gabriele, Pietro; Garibaldi, Elisabetta; Gómez-Caamaño, Antonio; Gutiérrez-Enríquez, Sara; Higginson, Daniel S; Johnson, Kerstie; Lobato-Busto, Ramón; Mollà, Meritxell; Müller, Anusha; Payne, Debbie; Peleteiro, Paula; Post, Giselle; Rancati, Tiziana; Rattay, Tim; Reyes, Victoria; Rosenstein, Barry S; De Ruysscher, Dirk; De Santis, Maria Carmen; Schäfer, Jörg; Schnabel, Thomas; Sperk, Elena; Symonds, R Paul; Stobart, Hilary; Taboada-Valladares, Begoña; Talbot, Christopher J; Valdagni, Riccardo; Vega, Ana; Veldeman, Liv; Ward, Tim; Weißenberger, Christian; West, Catharine M L; Chang-Claude, Jenny.
Afiliación
  • Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: p.seibold@dkfz-heidelberg.de.
  • Webb A; Department of Genetics and Genome Biology, University of Leicester, UK.
  • Aguado-Barrera ME; Fundación Pública Galega de Medicina Xenómica, Grupo de Medicina Xenómica (USC), Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela, Spain.
  • Azria D; Department of Radiation Oncology, Montpellier Cancer Institute, Université Montpellier, Inserm U1194, France.
  • Bourgier C; Department of Radiation Oncology, Montpellier Cancer Institute, Université Montpellier, Inserm U1194, France.
  • Brengues M; Institut de Recherche en Cancérologie de Montpellier, Montpellier Cancer Institute, Inserm U1194, France.
  • Briers E; Patient advocat, Hasselt, Belgium.
  • Bultijnck R; Department of Human Structure and Repair, Ghent University, Belgium.
  • Calvo-Crespo P; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
  • Carballo A; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
  • Choudhury A; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, UK.
  • Cicchetti A; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Claßen J; Klinik für Strahlentherapie, Radiologische Onkologie und Palliativmedizin, ViDia Christliche Kliniken Karlsruhe, Germany.
  • Delmastro E; Department of Radiation Oncology, Candiolo Cancer Institute - FPO, IRCCS, TO, Italy.
  • Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Research Labs, UK.
  • Elliott RM; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, UK.
  • Fachal L; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Research Labs, UK.
  • Farcy-Jacquet MP; Department of Radiation Oncology, CHU Nîmes, France.
  • Gabriele P; Department of Radiation Oncology, Candiolo Cancer Institute - FPO, IRCCS, TO, Italy.
  • Garibaldi E; Department of Radiation Oncology, Candiolo Cancer Institute - FPO, IRCCS, TO, Italy.
  • Gómez-Caamaño A; Instituto de Investigación Sanitaria de Santiago de Compostela, Spain; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
  • Gutiérrez-Enríquez S; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Higginson DS; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Johnson K; Leicester Cancer Research Centre, University of Leicester, UK.
  • Lobato-Busto R; Department of Medical Physics, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
  • Mollà M; Radiation Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Müller A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Payne D; Centre for Integrated Genomic Medical Research (CIGMR), University of Manchester, UK.
  • Peleteiro P; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
  • Post G; Department of Human Structure and Repair, Ghent University, Belgium.
  • Rancati T; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rattay T; Leicester Cancer Research Centre, University of Leicester, UK.
  • Reyes V; Radiation Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Rosenstein BS; Department of Radiation Oncology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.
  • De Ruysscher D; Maastricht University Medical Center, Department of Radiation Oncology (Maastro Clinic), GROW School for Oncology and Developmental Biology, Maastricht, the Netherlands; KU Leuven, Radiation Oncology, Leuven, Belgium.
  • De Santis MC; Department of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Schäfer J; Strahlentherapie Speyer, Germany.
  • Schnabel T; Klinik für Strahlentherapie und Radiologische Onkologie, Klinikum der Stadt Ludwigshafen gGmbH, Germany.
  • Sperk E; Department of Radiation Oncology, Universitätsklinikum Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Symonds RP; Leicester Cancer Research Centre, University of Leicester, UK.
  • Stobart H; Independent Cancer Patients' Voice, UK.
  • Taboada-Valladares B; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
  • Talbot CJ; Leicester Cancer Research Centre, University of Leicester, UK.
  • Valdagni R; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Haematology-Oncology, University of Milan, Italy.
  • Vega A; Fundación Pública Galega de Medicina Xenómica, Grupo de Medicina Xenómica (USC), Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela, Spain; Biomedical Network on Rare Diseases (CIBERER), Spain.
  • Veldeman L; Department of Human Structure and Repair, Ghent University, Belgium; Department of Radiation Oncology, Ghent University Hospital, Belgium.
  • Ward T; Trustee Pelvic Radiation Disease Association, NCRI CTRad Consumer, UK.
  • Weißenberger C; Zentrum für Strahlentherapie Freiburg, Germany.
  • West CML; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, UK.
  • Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Germany.
Radiother Oncol ; 138: 59-67, 2019 09.
Article en En | MEDLINE | ID: mdl-31146072
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Neoplasias de la Mama / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Radiother Oncol Año: 2019 Tipo del documento: Article Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Neoplasias de la Mama / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Radiother Oncol Año: 2019 Tipo del documento: Article Pais de publicación: Irlanda